{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:29:39Z","timestamp":1790501379040,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13075-015-0754-7","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T01:11:58Z","timestamp":1441933918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Macitentan inhibits the transforming growth factor-\u03b2 profibrotic action, blocking the signaling mediated by the ETR\/T\u03b2RI complex in systemic sclerosis dermal fibroblasts"],"prefix":"10.1186","volume":"17","author":[{"given":"Paola","family":"Cipriani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Di Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Verzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariafausta","family":"Fischietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Zazzeroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Liakouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Carubbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onorina","family":"Berardicurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Alesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,10]]},"reference":[{"key":"754_CR1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","volume":"8","author":"S Bhattacharyya","year":"2011","unstructured":"Bhattacharyya S, Wei J, Varga J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol. 2011;8:42\u201354.","journal-title":"Nat Rev Rheumatol"},{"key":"754_CR2","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1073\/pnas.0605669103","volume":"103","author":"KK Kim","year":"2006","unstructured":"Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A. 2006;103:13180\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"754_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1465-9921-8-1","volume":"8","author":"Z Wu","year":"2007","unstructured":"Wu Z, Yang L, Cai L, Zhang M, Cheng X, Yang X, et al. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Respir Res. 2007;8:1.","journal-title":"Respir Res"},{"key":"754_CR4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1165\/rcmb.2009-0031OC","volume":"43","author":"N Hashimoto","year":"2010","unstructured":"Hashimoto N, Phan SH, Imaizumi K, Matsuo M, Nakashima H, Kawabe T, et al. Endothelial mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2010;43:161\u201372.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"754_CR5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10456-013-9338-9","volume":"16","author":"P Cipriani","year":"2013","unstructured":"Cipriani P, Marrelli A, Di Benedetto P, Liakouli V, Carubbi F, Ruscitti P, et al. Scleroderma mesenchymal stem cells display a different phenotype from healthy controls; implications for regenerative medicine. Angiogenesis. 2013;16:595\u2013607.","journal-title":"Angiogenesis"},{"key":"754_CR6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s13075-014-0442-z","volume":"16","author":"P Cipriani","year":"2014","unstructured":"Cipriani P, Di Benedetto P, Ruscitti P, Campese AF, Liakouli V, Carubbi F, et al. Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features. Arthritis Res Ther. 2014;16:442.","journal-title":"Arthritis Res Ther"},{"key":"754_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-1536-7-13","volume":"7","author":"P Cipriani","year":"2014","unstructured":"Cipriani P, Di Benedetto P, Capece D, Zazzeroni F, Liakouli V, Ruscitti P, et al. Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis. Fibrogenesis Tissue Repair. 2014;7:13.","journal-title":"Fibrogenesis Tissue Repair"},{"key":"754_CR8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1139\/Y08-059","volume":"86","author":"M Barton","year":"2008","unstructured":"Barton M, Yanagisawa M. Endothelin: 20 years from discovery to therapy. Can J Physiol Pharmacol. 2008;86:485\u201398.","journal-title":"Can J Physiol Pharmacol"},{"key":"754_CR9","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1073\/pnas.86.8.2863","volume":"86","author":"A Inoue","year":"1989","unstructured":"Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989;86:2863\u201367.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"754_CR10","doi-asserted-by":"crossref","first-page":"R254","DOI":"10.1152\/ajpregu.00584.2009","volume":"298","author":"S Watts","year":"2010","unstructured":"Watts S. Endothelin receptors: what\u2019s new and what do we need to know? Am J Physiol Regul Integr Comp Physiol. 2010;298:R254\u201360.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"754_CR11","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1111\/j.1755-5922.2010.00158.x","volume":"28","author":"SG Raja","year":"2010","unstructured":"Raja SG. Endothelin receptor antagonists for pulmonary arterial hypertension: an overview. Cardiovasc Ther. 2010;28:e65\u201371.","journal-title":"Cardiovasc Ther"},{"key":"754_CR12","first-page":"106","volume":"21","author":"Z Razzaq","year":"2009","unstructured":"Razzaq Z, Hussain M, Naqvi S, Aslam M. Correlation of plasma endothelin-1 levels with pulmonary hypertension after inhaled nitric oxide therapy. J Ayub Med Coll Abbottabad. 2009;21:106\u201310.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"754_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1165\/ajrcmb.23.1.f192","volume":"23","author":"P Teder","year":"2000","unstructured":"Teder P, Noble PW. A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol. 2000;23:7\u201310.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"754_CR14","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1111\/j.1742-4658.2005.05016.x","volume":"272","author":"A Horstmeyer","year":"2005","unstructured":"Horstmeyer A, Licht C, Scherr G, Eckes B, Krieg T. Signalling and regulation of collagen I synthesis by ET-1 and TGF-beta1. FEBS J. 2005;272:6297\u2013309.","journal-title":"FEBS J"},{"key":"754_CR15","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.27307","volume":"62","author":"D Lagares","year":"2010","unstructured":"Lagares D, Garc\u00eda-Fern\u00e1ndez RA, Jim\u00e9nez CL, Mag\u00e1n-Marchal N, Busnadiego O, Lamas S, et al. Endothelin 1 contributes to the effect of transforming growth factor beta1 on wound repair and skin fibrosis. Arthritis Rheum. 2010;62:878\u201389.","journal-title":"Arthritis Rheum"},{"key":"754_CR16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1097-2765(03)00386-1","volume":"12","author":"MJ Goumans","year":"2003","unstructured":"Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGF\u03b2\/ALK5 signaling. Mol Cell. 2003;12:817\u201328.","journal-title":"Mol Cell"},{"key":"754_CR17","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/emboj\/21.7.1743","volume":"21","author":"MJ Goumans","year":"2002","unstructured":"Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF\u03b2 type I receptors. EMBO J. 2002;21:1743\u201353.","journal-title":"EMBO J"},{"key":"754_CR18","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1128\/MCB.01192-08","volume":"28","author":"AC Daly","year":"2008","unstructured":"Daly AC, Randall RA, Hill CS. Transforming growth factor beta-induced Smad1\/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol Cell Biol. 2008;28:6889\u2013902.","journal-title":"Mol Cell Biol"},{"key":"754_CR19","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.cellsig.2008.01.006","volume":"20","author":"A Leask","year":"2008","unstructured":"Leask A. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell Signal. 2008;20:1409\u201314.","journal-title":"Cell Signal"},{"key":"754_CR20","doi-asserted-by":"crossref","unstructured":"Cutolo M, Montagna P, Brizzolara R, Smith V, Alessandri E, Villaggio B, et al. Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts. J Rheumatol. 2015;42:456\u201363.","DOI":"10.3899\/jrheum.141070"},{"key":"754_CR21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.lfs.2014.02.018","volume":"118","author":"M Iglarz","year":"2014","unstructured":"Iglarz M, Bossu A, Wanner D, Bortolamiol C, Rey M, Hess P, et al. Comparison of pharmacological activity of macitentan and bosentan in preclinical models of systemic and pulmonary hypertension. Life Sci. 2014;118:333\u20139.","journal-title":"Life Sci"},{"key":"754_CR22","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"754_CR23","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747\u201355.","journal-title":"Ann Rheum Dis"},{"key":"754_CR24","first-page":"5","volume":"6","author":"S Bhattacharyya","year":"2012","unstructured":"Bhattacharyya S, Wei J, Tourtellotte WG, Hinchcliff M, Gottardi CG, Varga J. Fibrosis in systemic sclerosis: common and unique pathobiology. Fibrogenesis Tissue Repair. 2012;6:5. S18.","journal-title":"Fibrogenesis Tissue Repair"},{"key":"754_CR25","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.21725","volume":"54","author":"Y Chen","year":"2006","unstructured":"Chen Y, Shi-wen X, Eastwood M, Black CM, Denton CP, Leask A, et al. Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signalling to the fibrotic phenotype of scleroderma fibroblasts. Arthritis Rheum. 2006;54:1309\u201316.","journal-title":"Arthritis Rheum"},{"key":"754_CR26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","volume":"18","author":"A Leask","year":"2004","unstructured":"Leask A, Abraham DJ. TGF\u03b2 signaling and the fibrotic response. FASEB J. 2004;18:816\u201327.","journal-title":"FASEB J"},{"key":"754_CR27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00002281-200111000-00010","volume":"13","author":"CP Denton","year":"2001","unstructured":"Denton CP, Abraham DJ. Transforming growth factor-\u03b2 and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr Opin Rheumatol. 2001;13:505\u201311.","journal-title":"Curr Opin Rheumatol"},{"key":"754_CR28","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"WA Border","year":"1994","unstructured":"Border WA, Noble NA. Transforming growth factor \u03b2 in tissue fibrosis. N Engl J Med. 1994;331:1286\u201392.","journal-title":"N Engl J Med"},{"key":"754_CR29","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar4529","volume":"16","author":"K Akamata","year":"2014","unstructured":"Akamata K, Asano Y, Aozasa N, Noda S, Taniguchi T, Takahashi T, et al. Bosentan reverses the profibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1. Arthritis Res Ther. 2014;16:R86.","journal-title":"Arthritis Res Ther"},{"key":"754_CR30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1100\/tsw.2011.75","volume":"11","author":"PJ Little","year":"2011","unstructured":"Little PJ, Burch ML, Al-Aryahi S, Zheng W. The paradigm of G protein receptor transactivation: a mechanistic definition and novel example. Sci World J. 2011;11:709\u201314.","journal-title":"Sci World J"},{"key":"754_CR31","doi-asserted-by":"crossref","first-page":"26798","DOI":"10.1074\/jbc.M109.092767","volume":"285","author":"ML Burch","year":"2010","unstructured":"Burch ML, Ballinger ML, Yang SN, Getachew R, Itman C, Loveland K, et al. Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor \u03b2 type I receptor. J Biol Chem. 2010;285:26798\u2013805.","journal-title":"J Biol Chem"},{"key":"754_CR32","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1091\/mbc.E03-12-0902","volume":"15","author":"X Shi-Wen","year":"2004","unstructured":"Shi-Wen X, Chen Y, Denton CP, Eastwood M, Renzoni EA, Bou-Gharios G, et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac\/phosphoinositide 3-kinase\/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell. 2004;15:2707\u201319.","journal-title":"Mol Biol Cell"},{"key":"754_CR33","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1128\/MCB.00625-06","volume":"26","author":"X Shi-Wen","year":"2006","unstructured":"Shi-Wen X, Rodr\u00edguez-Pascual F, Lamas S, Holmes A, Howat S, Pearson JD, et al. Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors. Mol Cell Biol. 2006;26:5518\u201327.","journal-title":"Mol Cell Biol"},{"key":"754_CR34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.matbio.2007.06.003","volume":"26","author":"X Shi-Wen","year":"2007","unstructured":"Shi-Wen X, Renzoni EA, Kennedy L, Howat S, Chen Y, Pearson JD, et al. Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts. Matrix Biol. 2007;26:625\u201332.","journal-title":"Matrix Biol"},{"key":"754_CR35","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1002\/art.23134","volume":"56","author":"X Shi-wen","year":"2007","unstructured":"Shi-wen X, Kennedy L, Renzoni EA, Bou-Gharios G, du Bois RM, Black CM, et al. Endothelin is a downstream mediator of profibrotic responses to transforming growth factor b in human lung fibroblasts. Arthritis Rheum. 2007;56:4189\u201394.","journal-title":"Arthritis Rheum"},{"key":"754_CR36","first-page":"51","volume":"332","author":"K Natarajan","year":"2006","unstructured":"Natarajan K, Berk BC. Crosstalk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases. Methods Mol Biol. 2006;332:51\u201377.","journal-title":"Methods Mol Biol"},{"key":"754_CR37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/379557a0","volume":"379","author":"H Daub","year":"1996","unstructured":"Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature. 1996;379:557\u201360.","journal-title":"Nature"},{"key":"754_CR38","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1074\/jbc.273.12.6885","volume":"273","author":"AA Habib","year":"1998","unstructured":"Habib AA, H\u00f6gnason T, Ren J, Stef\u00e1nsson K, Ratan RR. The epidermal growth factor receptor associates with and recruits phosphatidylinositol 3-kinase to the platelet-derived growth factor beta receptor. J Biol Chem. 1998;273:6885\u201391.","journal-title":"J Biol Chem"},{"key":"754_CR39","doi-asserted-by":"crossref","first-page":"28578","DOI":"10.1074\/jbc.M102771200","volume":"276","author":"F Alderton","year":"2001","unstructured":"Alderton F, Rakhit S, Kong KC, Palmer T, Sambi B, Pyne S, et al. Tethering of the platelet-derived growth factor beta receptor to G-protein-coupled receptors. A novel platform for integrative signalling by these receptor classes in mammalian cells. J Biol Chem. 2001;276:28578\u201385.","journal-title":"J Biol Chem"},{"key":"754_CR40","doi-asserted-by":"crossref","first-page":"33035","DOI":"10.1074\/jbc.273.49.33035","volume":"273","author":"V Karoor","year":"1998","unstructured":"Karoor V, Wang L, Wang HY, Malbon CC. Insulin stimulates sequestration of beta-adrenergic receptors and enhanced association of beta-adrenergic receptors with Grb2 via tyrosine 350. J Biol Chem. 1998;273:33035\u201341.","journal-title":"J Biol Chem"},{"key":"754_CR41","doi-asserted-by":"crossref","first-page":"36086","DOI":"10.1074\/jbc.M004404200","volume":"275","author":"H Wang","year":"2000","unstructured":"Wang H, Doronin S, Malbon CC. Insulin activation of mitogen-activated protein kinases Erk1,2 is amplified via beta-adrenergic receptor expression and requires the integrity of the Tyr350 of the receptor. J Biol Chem. 2000;275:36086\u201393.","journal-title":"J Biol Chem"},{"key":"754_CR42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/rheumatology\/ken405","volume":"48","author":"I Badea","year":"2009","unstructured":"Badea I, Taylor M, Rosenberg A, Foldvari M. Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis. Rheumatology (Oxford). 2009;48:213\u201321.","journal-title":"Rheumatology (Oxford)"},{"key":"754_CR43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/rccm.200705-732OC","volume":"177","author":"TE King Jr","year":"2008","unstructured":"King Jr TE, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade JA, et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2008;177:75\u201381.","journal-title":"Am J Respir Crit Care Med"},{"key":"754_CR44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1164\/rccm.201011-1874OC","volume":"184","author":"TE King Jr","year":"2011","unstructured":"King Jr TE, Brown KK, Raghu G, du Bois RM, Lynch DA, Martinez F, et al. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;184:92\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"754_CR45","doi-asserted-by":"crossref","first-page":"v25","DOI":"10.1093\/rheumatology\/ken283","volume":"47","author":"RM Silver","year":"2008","unstructured":"Silver RM. Endothelin and scleroderma lung disease. Rheumatology (Oxford). 2008;47:v25\u20136.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0754-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T19:17:04Z","timestamp":1498245424000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.com\/content\/17\/1\/247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,10]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["754"],"URL":"https:\/\/doi.org\/10.1186\/s13075-015-0754-7","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,10]]},"article-number":"247"}}